Mobiquity Technologies’ AI Targeting Gains Traction with Political Advertisers as Election Season Kicks Off
26 avr. 2023 08h00 HE
|
Mobiquity Technologies, Inc.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology...
Mobiquity Technologies Enhances Real-Time Bidding with AI-Powered Ad Targeting
20 avr. 2023 08h00 HE
|
Mobiquity Technologies, Inc.
NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology...
Mobiquity Technologies Unveils ATOS 2.0: Harnessing AI and Bid-Based Learning to Optimize Advertising in an Increasingly Privacy-Centric World
17 avr. 2023 08h30 HE
|
Mobiquity Technologies, Inc.
NEW YORK, April 17, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology...
Cingulate to Participate in Benzinga All Live Access Event
14 avr. 2023 14h00 HE
|
Cingulate Inc.
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
TILT Holdings Announces April Conference Schedule
04 avr. 2023 07h30 HE
|
TILT Holdings Inc.
PHOENIX, April 04, 2023 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301 (dexmethylphenidate) for ADHD
04 avr. 2023 06h45 HE
|
Cingulate Inc.
Trial On Track for 3Q 2023 Results Pivotal Phase 3 Trial in Pediatric/Adolescent Patients Planned to Begin Mid-2023 KANSAS CITY, Kan., April 04, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:...
Mobiquity Technologies Unveils ATOS 2.0: A New and Improved Privacy-Centric Advertising Platform
23 mars 2023 08h30 HE
|
Mobiquity Technologies, Inc.
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technologies,...
Mobiquity Adds Industry Veteran, Brett Perloff, to Head-Up Revenue in Anticipation of New Product Launch
16 mars 2023 08h30 HE
|
Mobiquity Technologies, Inc.
NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technologies, today...
Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301
13 mars 2023 06h45 HE
|
Cingulate Inc.
Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in...
Cingulate Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
10 mars 2023 16h05 HE
|
Cingulate Inc.
CTx-1301 Phase 3 Adult Dose-Optimization Study Ongoing; Results Expected 3Q 2023 Positive Top-Line Data from CTx-1301 Fed/Fast Study Announced, Full Results Submitted for Presentation at Forthcoming...